These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 173386)

  • 21. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thin-layer immunoassay for determination of antibodies to herpes simplex virus.
    Jeansson S; Elwing H; Nilsson LA
    J Clin Microbiol; 1979 Mar; 9(3):317-22. PubMed ID: 222798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
    Arsenakis M; May JT
    Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial herpes simplex infection associated with activation of the complement system.
    Kapadia A; Gupta S; Good RA; Day NK
    Am J Med; 1979 Jul; 67(1):122-6. PubMed ID: 380333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune responses to herpes simplex virus in patients with facial herpes simplex and those with eczema herpeticum.
    Vestey JP; Howie SE; Norval M; Maingay JP; Neill WA
    Br J Dermatol; 1988 Jun; 118(6):775-82. PubMed ID: 2840941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
    Polack FM; Habash N; Zam ZS; Burdette MG
    Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IgA antibodies in HSV asymptomatic genital infections.
    Guglielmino SP; Garozzo A; Pinizzotto MR; Furneri PM; Corbino N; Castro A; Cianci S
    J Med Virol; 1989 Mar; 27(3):210-4. PubMed ID: 2542431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.
    Reichman RC; Dolin R; Vincent MM; Fauci AS
    Proc Soc Exp Biol Med; 1977 Sep; 155(4):571-6. PubMed ID: 197538
    [No Abstract]   [Full Text] [Related]  

  • 32. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S
    Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
    Russell AS; Essery G
    Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of a conjugate of staphylococcal protein A with peroxidase in an immunoenzyme test system for determining antibodies to the herpes simplex virus].
    Leonov SV; Posevaia TA; Zakomyrdin IuA; Semenova TB; Dekonenko EP
    Vopr Virusol; 1986; 31(3):321-5. PubMed ID: 3020799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral response to herpes simplex virus type 1 in latent and active infection.
    Santiago J; Gomez B
    J Infect Dis; 1988 Apr; 157(4):817-9. PubMed ID: 2831287
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
    Russell AS; Kaiser JT
    J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the FIAX test for the detection of antibodies to herpes simplex virus and cytomegalovirus.
    Segar JE; Smith TF; Ilstrup DM
    Am J Clin Pathol; 1981 Mar; 75(3):387-90. PubMed ID: 6259930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.